Carbapenem resistance represents a pressing public health concern, posing significant challenges due to limited treatment options and escalating mortality rates. In India, the prevalence of carbapenem resistance among Enterobacteriaceae ranges between 18 to 31%, causing severe infections such as bloodstream infections, pneumonia, urinary tract infections, and intra-abdominal infections. Accurate and timely diagnosis, particularly for Enterobacteriaceae producing carbapenemase, is crucial for effective clinical prophylaxis of critical care patients as they are considered as a last resort of therapy. Various genotypic and non-genotypic detection methods have been developed over the past decade, their limitations in terms of sensitivity and specificity have led the exploration of innovative technologies. Advanced opportunities for carbapenem resistance detection using microfluidic-based biosensors have miniaturized various biomedical devices. This enables the use of less sample and reagents, cheap pricing, automation, screening, and improved detection. Despite ongoing research and development, the adoption of these biosensors in healthcare settings is limited due to the lack of awareness and understanding of their efficiency. Therefore, this review primarily focuses on the advantages and limitations of all biosensor-based devices over existing methods for the detection of carbapenem resistance in gram negative bacilli. These biosensors represent substantial advancements in combating carbapenem resistance, providing promise for more reliable and accurate diagnostic techniques that may eventually improve patient care and infection control.
{"title":"Next-Gen Nano Biosensor Technologies to Monitor Carbapenem Resistance for Personalized Medicine","authors":"Rahul Harikumar Lathakumari, Leela Kakithakara Vajravelu, Jayaprakash Thulukanam, Ashwin Kumar Narasimhan","doi":"10.1007/s12088-024-01337-z","DOIUrl":"https://doi.org/10.1007/s12088-024-01337-z","url":null,"abstract":"<p>Carbapenem resistance represents a pressing public health concern, posing significant challenges due to limited treatment options and escalating mortality rates. In India, the prevalence of carbapenem resistance among Enterobacteriaceae ranges between 18 to 31%, causing severe infections such as bloodstream infections, pneumonia, urinary tract infections, and intra-abdominal infections. Accurate and timely diagnosis, particularly for Enterobacteriaceae producing carbapenemase, is crucial for effective clinical prophylaxis of critical care patients as they are considered as a last resort of therapy. Various genotypic and non-genotypic detection methods have been developed over the past decade, their limitations in terms of sensitivity and specificity have led the exploration of innovative technologies. Advanced opportunities for carbapenem resistance detection using microfluidic-based biosensors have miniaturized various biomedical devices. This enables the use of less sample and reagents, cheap pricing, automation, screening, and improved detection. Despite ongoing research and development, the adoption of these biosensors in healthcare settings is limited due to the lack of awareness and understanding of their efficiency. Therefore, this review primarily focuses on the advantages and limitations of all biosensor-based devices over existing methods for the detection of carbapenem resistance in gram negative bacilli. These biosensors represent substantial advancements in combating carbapenem resistance, providing promise for more reliable and accurate diagnostic techniques that may eventually improve patient care and infection control.</p>","PeriodicalId":13316,"journal":{"name":"Indian Journal of Microbiology","volume":"26 1","pages":""},"PeriodicalIF":3.0,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141510960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-20DOI: 10.1007/s12088-024-01333-3
Min Zhang, Bing Yan
To investigate the characteristics and risk factors of cytomegalovirus (CMV) infection in patients with dermatomyositis (DM) and explore whether CMV infection plays a role in the prognosis of patients with DM. The retrospective reviewed patients with DM admitted to the hospital from October 2017 to June 2022 and the enrolled patients who were assessed for CMV infection. The clinical characteristics and prognosis of the patients with CMV infection were compared to those without CMV. Of the 181 patients with DM, 53 (29.2%) suffered from CMV infection. The prevalence of CMV infection in the anti-MDA5( +) DM group was higher than it was in the anti-MDA5(-) DM group (38.7% vs. 16.0%, P = 0.001). Multivariate analyses demonstrated that the ILD (OR 5.11, 95% CI 1.74–15.26, P = 0.003), other infections (OR 6.24, 95% CI 1.63–23.89, P = 0.007), the cumulative dose of glucocorticoids (OR 5.19, 95% CI 2.44–11.02, P < 0.001), usage of CTX (OR 8.49, 95% CI 2.28–31.54, P = 0.001), ALB ≦ 30 g/L (OR 3.19, 95% CI 1.03–9.85, P = 0.043) were independent risk factors for CMV infection in patients with DM. Patients in the CMV-infection group showed significantly higher incidences of other infections than those in the CMV-infection-negative group. Higher mortality was observed in the CMV infection group than in the without CMV infection group. CMV infection occurred in patients with DM frequently and was found to be relevant to death. The cumulative dose of glucocorticoids, ILD, useage of CTX, hypoproteinemia, and other infections were contributing factors in the development of CMV infection in patieents with DM.
目的 研究皮肌炎(DM)患者巨细胞病毒(CMV)感染的特征和风险因素,探讨CMV感染是否对DM患者的预后起作用。该研究回顾性分析了2017年10月至2022年6月该院收治的DM患者,并对入选患者进行了CMV感染评估。将感染CMV的患者与未感染CMV的患者的临床特征和预后进行了比较。在181名DM患者中,53人(29.2%)患有CMV感染。抗MDA5(+) DM组的CMV感染率高于抗MDA5(-) DM组(38.7%对16.0%,P = 0.001)。多变量分析表明,ILD(OR 5.11,95% CI 1.74-15.26,P = 0.003)、其他感染(OR 6.24,95% CI 1.63-23.89,P = 0.007)、糖皮质激素累积剂量(OR 5.19,95% CI 2.44-11.02,P < 0.001)、使用 CTX(OR 8.49,95% CI 2.28-31.54,P = 0.001)、ALB ≦ 30 g/L(OR 3.19,95% CI 1.03-9.85,P = 0.043)是 DM 患者 CMV 感染的独立危险因素。CMV感染组患者的其他感染发生率明显高于CMV感染阴性组。CMV感染组的死亡率高于无CMV感染组。CMV感染经常发生在DM患者中,并被发现与死亡有关。糖皮质激素的累积剂量、ILD、使用CTX、低蛋白血症和其他感染是DM患者发生CMV感染的诱因。
{"title":"The Characteristics and Risk Factors of Cytomegalovirus Infection in Dermatomyositis","authors":"Min Zhang, Bing Yan","doi":"10.1007/s12088-024-01333-3","DOIUrl":"https://doi.org/10.1007/s12088-024-01333-3","url":null,"abstract":"<p>To investigate the characteristics and risk factors of cytomegalovirus (CMV) infection in patients with dermatomyositis (DM) and explore whether CMV infection plays a role in the prognosis of patients with DM. The retrospective reviewed patients with DM admitted to the hospital from October 2017 to June 2022 and the enrolled patients who were assessed for CMV infection. The clinical characteristics and prognosis of the patients with CMV infection were compared to those without CMV. Of the 181 patients with DM, 53 (29.2%) suffered from CMV infection. The prevalence of CMV infection in the anti-MDA5( +) DM group was higher than it was in the anti-MDA5(-) DM group (38.7% vs. 16.0%, <i>P</i> = 0.001). Multivariate analyses demonstrated that the ILD (OR 5.11, 95% CI 1.74–15.26, <i>P</i> = 0.003), other infections (OR 6.24, 95% CI 1.63–23.89, <i>P</i> = 0.007), the cumulative dose of glucocorticoids (OR 5.19, 95% CI 2.44–11.02, <i>P < </i>0.001), usage of CTX (OR 8.49, 95% CI 2.28–31.54, <i>P</i> = 0.001), ALB ≦ 30 g/L (OR 3.19, 95% CI 1.03–9.85, <i>P</i> = 0.043) were independent risk factors for CMV infection in patients with DM. Patients in the CMV-infection group showed significantly higher incidences of other infections than those in the CMV-infection-negative group. Higher mortality was observed in the CMV infection group than in the without CMV infection group. CMV infection occurred in patients with DM frequently and was found to be relevant to death. The cumulative dose of glucocorticoids, ILD, useage of CTX, hypoproteinemia, and other infections were contributing factors in the development of CMV infection in patieents with DM.</p>","PeriodicalId":13316,"journal":{"name":"Indian Journal of Microbiology","volume":"8 1","pages":""},"PeriodicalIF":3.0,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141510966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-20DOI: 10.1007/s12088-024-01328-0
Fitsum Dejene, Fitsum Wubishet, R. S. Suresh Kumar, Aseer Manilal, Aweke Mamo, Thanigaivel Sundaram
In this study, soil samples from textile industries located in the Arba Minch region were collected and screened for the presence of heavy-metal-resistant fungi. Among the three isolates identified during the screening process, Aspergillus flavus exhibited the highest resistance to heavy metals such as Cr (VI) and Mn (II). Our results showed that A. flavus biosorbed Mn and Cr at concentrations of 80.5% and 68.4%, respectively, making it a promising biosorbing agent. Furthermore, our study demonstrated that pretreatment of A. flavus fungal biomass with NaOH enhanced the biosorption of Mn and Cr. To optimize the biosorption process, a study was conducted using A. flavus biomass with three independent variables: pH (2–10), biomass dosage (1–5 g/mL), and contact time (40–150 min). The Box-Behnken experimental design was used to determine the optimal biosorption values. Maximum biosorption was achieved at pH 10, biomass dosage (5 g/mL), and contact time of 150 min. These conditions resulted in 88 and 80.29% sorption efficiency for manganese and chromium ions, respectively, by A. flavus biomass. The scanning electron microscopic analysis of A. flavus biomass indicated the presence of large porosities on the microbial surface due to NaOH treatment, which assisted in the higher sorption of heavy metals.
{"title":"Optimisation of Aspergilus flavus-Mediated Biosorption Process for Removal of Cr (VI) and Mn (II) Ions by Response Surface Methodology Approach","authors":"Fitsum Dejene, Fitsum Wubishet, R. S. Suresh Kumar, Aseer Manilal, Aweke Mamo, Thanigaivel Sundaram","doi":"10.1007/s12088-024-01328-0","DOIUrl":"https://doi.org/10.1007/s12088-024-01328-0","url":null,"abstract":"<p>In this study, soil samples from textile industries located in the Arba Minch region were collected and screened for the presence of heavy-metal-resistant fungi. Among the three isolates identified during the screening process, <i>Aspergillus flavus</i> exhibited the highest resistance to heavy metals such as Cr (VI) and Mn (II). Our results showed that A. flavus biosorbed Mn and Cr at concentrations of 80.5% and 68.4%, respectively, making it a promising biosorbing agent. Furthermore, our study demonstrated that pretreatment of <i>A. flavus</i> fungal biomass with NaOH enhanced the biosorption of Mn and Cr. To optimize the biosorption process, a study was conducted using <i>A. flavus</i> biomass with three independent variables: pH (2–10), biomass dosage (1–5 g/mL), and contact time (40–150 min). The Box-Behnken experimental design was used to determine the optimal biosorption values. Maximum biosorption was achieved at pH 10, biomass dosage (5 g/mL), and contact time of 150 min. These conditions resulted in 88 and 80.29% sorption efficiency for manganese and chromium ions, respectively, by <i>A. flavus</i> biomass. The scanning electron microscopic analysis of <i>A. flavus</i> biomass indicated the presence of large porosities on the microbial surface due to NaOH treatment, which assisted in the higher sorption of heavy metals.</p>","PeriodicalId":13316,"journal":{"name":"Indian Journal of Microbiology","volume":"61 1","pages":""},"PeriodicalIF":3.0,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141530270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
C-Phycocyanin (C-PC), is a natural blue pigment found mainly in cyanobacteria. Due to its extraordinary spectral properties and unique health benefits, this pigment has attracted significant attention in various industries. C-PC is widely studied and reported to have different pharmacological properties, notably antioxidant, anti-inflammatory, anti-cancer, neuroprotective, and hepatoprotective activities. Commercial exploitation of cyanobacterial phycocyanin relies on mass cultivation of selected cyanobacteria using different strategies like phototrophic, heterotrophic, mixotrophic, two-stage, open, and closed systems. Nonetheless, the production is influenced by different environmental factors especially light, pH and temperature as well as the availability of high yielding strains. Some of the bottlenecks like breaking the genetic barrier of sub-optimal yield or response to environmental factors can be addressed by genetic and metabolic engineering using advanced molecular tools. The present review discusses the production and application of C-PC along with possible molecular interventions to improve C-PC production. We have also discussed how strain improvement and diversified application can harness the commercial potential of C-PC in future to a greater extent.
{"title":"Production and Applications of Cyanobacterial Phycocyanin: Trends and Prospects","authors":"Diya Roy, Shaloo Verma, Sudipta Das, Hillol Chakdar, Sunil Pabbi","doi":"10.1007/s12088-024-01332-4","DOIUrl":"https://doi.org/10.1007/s12088-024-01332-4","url":null,"abstract":"<p>C-Phycocyanin (C-PC), is a natural blue pigment found mainly in cyanobacteria. Due to its extraordinary spectral properties and unique health benefits, this pigment has attracted significant attention in various industries. C-PC is widely studied and reported to have different pharmacological properties, notably antioxidant, anti-inflammatory, anti-cancer, neuroprotective, and hepatoprotective activities. Commercial exploitation of cyanobacterial phycocyanin relies on mass cultivation of selected cyanobacteria using different strategies like phototrophic, heterotrophic, mixotrophic, two-stage, open, and closed systems. Nonetheless, the production is influenced by different environmental factors especially light, pH and temperature as well as the availability of high yielding strains. Some of the bottlenecks like breaking the genetic barrier of sub-optimal yield or response to environmental factors can be addressed by genetic and metabolic engineering using advanced molecular tools. The present review discusses the production and application of C-PC along with possible molecular interventions to improve C-PC production. We have also discussed how strain improvement and diversified application can harness the commercial potential of C-PC in future to a greater extent.</p>","PeriodicalId":13316,"journal":{"name":"Indian Journal of Microbiology","volume":"12 1","pages":""},"PeriodicalIF":3.0,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141510967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-19DOI: 10.1007/s12088-024-01327-1
Natasha Kudesia, A. Najitha Banu
The current study is based on the synthesis of silver nanoparticles using Aspergillus fumigatus and its larvicidal activity against Aedes aegyptii. The optical, morphological, structural, and elemental properties of synthesized silver nanoparticles were investigated by UV–Vis spectroscopy, Scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), Energy-dispersive X-ray analysis (EDX) and Zeta potential. The characterization was confirmed by the surface plasmon resonance band at 434 nm. The results validated the spherical shape and size (28–33 nm) of the nanoparticles. Biosynthesized silver nanoparticles (AgNPs) have been evaluated for their effectiveness in controlling Aedes aegyptii larvae. The larvicidal effect was evident in the experiment when Aedes larvae were exposed to five different log concentrations of Aspergillus fumigatus based-AgNPs. The mortality in the larvae had been observed at various exposure times. Exposure of third instar larvae of Aedes aegypti to biosynthesized silver nanoparticles resulted in lethal concentrations (LC50 and LC90) of 2.624 and 4.728 ppm, respectively. Moreover, the biotoxicity screening against non-target organism Daphnia magna revealed the nontoxic nature of biogenic nanosilver against non-target fauna. The findings indicate that Aspergillus fumigatus has the potential to facilitate the swift synthesis of silver nanoparticles, presenting a novel approach for vector control strategies, without causing any harm to other aquatic organisms occupying the same ecological niche.
{"title":"Larvicidal Efficacy of Green Synthesized Silver Nanoparticles on Aedes aegyptii and its Impact on Nontarget Daphnia magna","authors":"Natasha Kudesia, A. Najitha Banu","doi":"10.1007/s12088-024-01327-1","DOIUrl":"https://doi.org/10.1007/s12088-024-01327-1","url":null,"abstract":"<p>The current study is based on the synthesis of silver nanoparticles using <i>Aspergillus fumigatus</i> and its larvicidal activity against <i>Aedes aegyptii.</i> The optical, morphological, structural, and elemental properties of synthesized silver nanoparticles were investigated by UV–Vis spectroscopy, Scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), Energy-dispersive X-ray analysis (EDX) and Zeta potential. The characterization was confirmed by the surface plasmon resonance band at 434 nm. The results validated the spherical shape and size (28–33 nm) of the nanoparticles. Biosynthesized silver nanoparticles (AgNPs) have been evaluated for their effectiveness in controlling <i>Aedes aegyptii</i> larvae. The larvicidal effect was evident in the experiment when <i>Aedes</i> larvae were exposed to five different log concentrations of <i>Aspergillus fumigatus</i> based-AgNPs. The mortality in the larvae had been observed at various exposure times. Exposure of third instar larvae of <i>Aedes aegypti</i> to biosynthesized silver nanoparticles resulted in lethal concentrations (LC<sub>50</sub> and LC<sub>90</sub>) of 2.624 and 4.728 ppm, respectively. Moreover, the biotoxicity screening against non-target organism <i>Daphnia magna</i> revealed the nontoxic nature of biogenic nanosilver against non-target fauna. The findings indicate that <i>Aspergillus fumigatus</i> has the potential to facilitate the swift synthesis of silver nanoparticles, presenting a novel approach for vector control strategies, without causing any harm to other aquatic organisms occupying the same ecological niche.</p>","PeriodicalId":13316,"journal":{"name":"Indian Journal of Microbiology","volume":"14 1","pages":""},"PeriodicalIF":3.0,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141530142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Multidrug-resistant Klebsiella pneumoniae (MDR-KP) infections have become a major global issue in the healthcare sector. Alternative viable tactics for combating bacterial infections, such as the use of bacteriophages, can be considered. One of the major challenges in phage therapy is the emergence of phage-resistant bacteria. This study isolated bacteriophages from water and soil samples against MDR-KP isolates. Susceptible bacterial hosts were exposed to phages at different concentrations and prolonged durations of time to obtain phage-resistant survivors. Phenotypic changes such as changes in growth rates, biofilm formation ability, antibiotic sensitivity patterns, and outer membrane proteins (OMPs) profiling of the survivors were studied. Our findings indicate that the phage ØKp11 and ØKp26 survivors had reduced growth rates and biofilm formation ability, altered antibiotic sensitivity patterns, and reduced OMPs expression compared with the parent MDR-KP002 isolate. These results suggest that the alternations in the bacterial envelope result in phenotypic phage resistance among MDR bacterial isolates.
{"title":"Phenotypic Changes in Phage Survivors of Multidrug-Resistant Klebsiella pneumoniae","authors":"Pallavi Bhat Ajakkala, Srajana Nayak, Biswajit Maiti, Anusha Rohit, Juliet Roshini Mohan Raj, Indrani Karunasagar","doi":"10.1007/s12088-024-01217-6","DOIUrl":"https://doi.org/10.1007/s12088-024-01217-6","url":null,"abstract":"<p>Multidrug-resistant <i>Klebsiella pneumoniae</i> (MDR-KP) infections have become a major global issue in the healthcare sector. Alternative viable tactics for combating bacterial infections, such as the use of bacteriophages, can be considered. One of the major challenges in phage therapy is the emergence of phage-resistant bacteria. This study isolated bacteriophages from water and soil samples against MDR-KP isolates. Susceptible bacterial hosts were exposed to phages at different concentrations and prolonged durations of time to obtain phage-resistant survivors. Phenotypic changes such as changes in growth rates, biofilm formation ability, antibiotic sensitivity patterns, and outer membrane proteins (OMPs) profiling of the survivors were studied. Our findings indicate that the phage ØKp11 and ØKp26 survivors had reduced growth rates and biofilm formation ability, altered antibiotic sensitivity patterns, and reduced OMPs expression compared with the parent MDR-KP002 isolate. These results suggest that the alternations in the bacterial envelope result in phenotypic phage resistance among MDR bacterial isolates.</p>","PeriodicalId":13316,"journal":{"name":"Indian Journal of Microbiology","volume":"15 1","pages":""},"PeriodicalIF":3.0,"publicationDate":"2024-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141256077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Microgravity is a state of free fall which one experiences in space. Human-crewed missions are becoming more sophisticated in the ongoing times. The altered gravitational conditions exert several physiological changes in the astronauts. Among many, one of the significantly affected systems and least discussed so far is the neurological system. Earlier studies have shown that exposure to space condition leads to structural changes in the brain, including distorted neurons and apoptotic astrocytes. Recent studies show the velocity of the action potential is reduced. Hippocampal activity is disrupted leading to cognitive impairment. Neuro ocular change occurs in some astronauts. Probiotics like Bacillus coagulans and Lactobacillus sp. connect gut-brain axis. Several probiotics are effective in treating neurological structural disorders. To sum up, in orbital exploration, astronauts face challenges of cosmic radiation and microgravity, impacting neuronal morphology. Chronic low-dose X-ray exposure delays neurite outgrowth and induces apoptosis. Simulated microgravity intensifies these effects, causing a significant increase in late apoptotic neurons. Astrocytes exposed to microgravity undergo apoptosis, but surviving cells adapt. Microgravity induces cellular senescence in rat cells, mimicking aging. NASA Twin Study reveals cognitive declines post-microgravity. Probiotics show therapeutic potential in neurological disorders, influencing gene expression and apoptotic proteins. They alleviate neurodegeneration and delay senescence, emphasizing their role in neurological well-being. In this review we discuss baseline data in this area since few laboratories has started working on the effect of nanoparticles on probiotics under microgravity. This review would help us and others interested in this field worldwide to work cohesively in future.